Samalin Investment Counsel, LLC Cel Sci Corp Transaction History

Samalin Investment Counsel, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$2.58 - $4.99 $206 - $399	-80 Closed	0 $0
Q2 2021 Aug 12, 2021	BUY	$8.68 - $27.49 $694 - $2,199	80 New	80 $0
Q1 2021 May 11, 2021	SELL	$12.0 - $27.64 $960 - $2,211	-80 Closed	0 $0
Q3 2020 Nov 10, 2020	BUY	$11.69 - $14.54 $935 - $1,163	80 New	80 $1,000
Q1 2020 May 04, 2020	SELL	$7.54 - $17.05 $603 - $1,364	-80 Closed	0 $0
Q4 2019 Feb 05, 2020	BUY	$6.71 - $9.55 $536 - $764	80 New	80 $0

27.1K

150K

Ticker CVM
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,367,500
Market Cap $26.9M
Description
CEL-SCI Corporation engages in the research and development of immunotherapy for the treatment of cancer and infectious diseases. The company's lead investigational immunotherapy is Multikine, which is under phase III clinical trial for the treatment of head and neck cancer. Its Ligand Epitope Antigen Presentation System (LEAPS), a pre-clinical ...

Get notified when there are updates to the investment portfolio of Samalin Investment Counsel, LLC, based on Form 13F filings with the SEC.

Stay updated on Samalin Investment Counsel, LLC with notifications on news.